Progressive Care Leadership Announces Shareholder Conference Call and Business Update on December 7th, 2020
December 03 2020 - 8:10AM
InvestorsHub NewsWire
RXMD Management to Discuss Details Regarding Recently
Filed Proxy Statement and Address Shareholder Questions Submitted
in Advance
MIAMI, FL -- December 3, 2020 -- InvestorsHub
NewsWire -- Progressive Care Inc.
(OTCQB:
RXMD), a personalized healthcare services and technology
company, is pleased to announce that the Company has scheduled an
investor conference call for 4:30 PM ET on Monday, December 7,
2020.
The Company will address the
recently filed proxy statement. In addition, interested parties can
submit questions concerning the Company to Stuart Smith at
SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 5:00
PM ET on Friday, December 4, 2020. In determining the questions
that will be addressed, the Company will use its discretion,
considering factors such as relevance to the entire shareholder
base and appropriateness in light of compliance requirements under
applicable securities laws.
To access the
call:
Dial-In Number: 1-857-232-0157
Access Code:
422095
For those unable to participate in the live
conference call, a replay will be available
at https://www.smallcapvoice.com/clients/rxmd/shortly after the call has
concluded. An archived version of the webcast will also be
available https://www.progressivecareus.com/news-releases.
Connect and stay in touch with us on social
media:
Progressive Care
Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo
Rx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
Progressive Care Inc. (RXMD), through its
subsidiaries, is a Florida technology and health services
organization that provides prescription pharmaceuticals, compounded
medications, provider of tele-pharmacy services, the sale of
anti-retroviral medications, medication therapy management (MTM),
the supply of prescription medications to long-term care
facilities, and health practice risk management. Cautionary
Statement Regarding Forward-Looking Statements: Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company’s expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
“anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,”
“intend” and “expect” and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company’s
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking
statements.
Public Relations
Contact:
Carlos
Rangel
carlosr@pharmcorx.com
www.progressivecareus.com
www.pharmcopharmacy.com
For SmallCapVoice.com,
Inc.
Stuart T. Smith
512-267-2430
ssmith@smallcapvoice.com
www.SmallCapVoice.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024